Cross Country Healthcare Q4 2020 Earnings Report
Key Takeaways
Cross Country Healthcare's Q4 2020 performance demonstrated its ability to deliver critical staff and support, with revenue at $215.6 million, flat year-over-year but up 11% sequentially, and net income attributable to common shareholders at $4.6 million, a significant improvement from prior periods.
Consolidated revenue for the fourth quarter was $215.6 million, representing an 11% sequential increase.
Consolidated gross margin was 25.2%, up 50 basis points year-over-year and sequentially.
Net income attributable to common shareholders was $4.6 million, a significant improvement from the prior year and quarter.
Adjusted EPS was $0.19, compared to $0.07 in the prior year.
Cross Country Healthcare
Cross Country Healthcare
Cross Country Healthcare Revenue by Segment
Forward Guidance
The company provided guidance for Q1 2021, anticipating revenue between $280 million and $295 million and adjusted EPS between $0.32 and $0.37.
Positive Outlook
- Sequential increases in bill rates
- Increase in the number of clinicians on COVID assignments
- Continued closures of schools in key markets
- Revenue between $280 million and $295 million
- Adjusted EPS between $0.32 and $0.37
Challenges Ahead
- High degree of uncertainty regarding the continued impact from COVID-19
- Potential impact of any future divestitures
- Potential impact of mergers, acquisitions or other business combinations
- Potential impact of changes in debt structure
- Potential impact of future share repurchases
Revenue & Expenses
Visualization of income flow from segment revenue to net income